Definition and classification of cancer cachexia: an international consensus.
Kenneth Fearon, Florian Strasser, Stefan D Anker...
https://pubmed.ncbi.nlm.nih.gov/21296615/Actively Recruiting
Led by Academisch Ziekenhuis Maastricht · Updated on 2025-08-24
300
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are investigating cachexia, a syndrome involving significant loss of body weight and muscle mass that affects cancer patients quality of life, survival, and treatment outcomes. The study aims to improve the accuracy of cachexia diagnosis by comparing self-reported weight changes with objective measurements taken before treatment. This pilot study involves patients aged 18 and older undergoing curative-intent chemotherapy or surgery for various cancers, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal, and ovarian cancers. Participants will undergo extensive pre-treatment assessments including physical tests, body measurements, and laboratory tests. They will receive a weight scale and an accelerometer to measure daily body weight and physical activity at home. For chemotherapy patients, monitoring starts at initial clinic presentation, continues through treatment, and ends two weeks after chemotherapy. For surgical patients, monitoring pauses during hospital stay and resumes after discharge until follow-up. Imaging and body composition analyses will be performed before and after treatment. Throughout the study, researchers will record treatment-related adverse events, response to therapy, survival, and disease-free survival for up to five years. Physical activity, body composition, and other cachexia-related parameters will also be analyzed. Data will be collected via tests, scans, questionnaires, and equipment use, with adverse events classified by established criteria. This comprehensive monitoring aims to better understand cachexias impact and improve diagnosis accuracy in cancer care.
CONDITIONS
Patient Recorded Indexing Measurements
N
Nicole Hildebrand, M.D.
S
Sander Rensen, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Academisch Ziekenhuis Maastricht
Lead Sponsor
Zuyderland Medisch Centrum
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for extensive pre-treatment physical and anthropometric assessments and blood sampling
Duration - 5 to 14 weeks on average, depending on treatment type and length
Participants use a weight scale daily at home and wear an accelerometer continuously to monitor body weight and physical activity throughout their treatment.
Daily use of weight scale and continuous accelerometer wear during treatment
Duration - Hospital stay plus 2 to 3 weeks post-discharge
For participants undergoing surgery, monitoring pauses during hospital stay and resumes after discharge until regular follow-up.
Monitoring paused during hospital stay; resumed after discharge until follow-up visit
Duration - 2 to 3 weeks after treatment completion, with long-term survival follow-up up to 5 years
Participants return equipment and undergo routine CT scans and assessments to evaluate treatment response and body composition after treatment completion.
1 follow-up visit for equipment return and assessment; additional long-term monitoring for survival outcomes
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Kenneth Fearon, Florian Strasser, Stefan D Anker...
https://pubmed.ncbi.nlm.nih.gov/21296615/Marianne Latrille, Nicolas C Buchs, Frédéric Ris...
https://pubmed.ncbi.nlm.nih.gov/34941028/David P J van Dijk, Maikel J A M Bakens, Mariëlle M E Coolsen...
https://pubmed.ncbi.nlm.nih.gov/27897432/Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/Connie Yip, Vicky Goh, Andrew Davies...
https://pubmed.ncbi.nlm.nih.gov/24535076/N Harimoto, K Shirabe, Y-I Yamashita...
https://pubmed.ncbi.nlm.nih.gov/24037576/Go Ninomiya, Tsutomu Fujii, Suguru Yamada...
https://pubmed.ncbi.nlm.nih.gov/28110029/E A Eisenhauer, P Therasse, J Bogaerts...
https://pubmed.ncbi.nlm.nih.gov/19097774/Amanda B Cooper, Rebecca Slack, David Fogelman...
https://pubmed.ncbi.nlm.nih.gov/25519927/Carla M M Prado, Vickie E Baracos, Linda J McCargar...
https://pubmed.ncbi.nlm.nih.gov/19351764/Academisch Ziekenhuis Maastricht
Lead Sponsor
Zuyderland Medisch Centrum
Collaborating Sponsor